Oncology Companion Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

  • Single User License $3500

Oncology Companion Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

Status : November, 2021 | Medical Devices

Report Digest


Global Oncology Companion Diagnostic Market: Overview

Companion diagnostics are developed along with drugs so as to assist in the exclusion or selection of groups for the purpose of treating patients with a certain drug, based on biological characteristics of the selected pool of patients. It is these characteristics that determine who are non-responders and who are the responders to the therapy. The development of the global oncology companion diagnostic market is likely to be driven by the evolution and progress made in the cancer treatment sector. The US-based food and drug administration (FDA) has already given approval for single-agent regimens and ten new combinations, which are being utilized with a certain CDx assay from the beginning of January 2020.

The major players in the global oncology companion diagnostic market are constantly focusing on new product launches and approvals in this market space. This factor is likely to drive the demand for oncology companion diagnostic in the years to come. Immunohistochemistry (IHC) – based CDx assists in the process of rapid drug development and often results in successful approvals.

Product and service, technology, disease type, and region are the four key parameters based on which the global oncology companion diagnostic market has been divided. The objective of such segmentation is to offer a clearer, 360-degree view of the market.

Global Oncology Companion Diagnostic Market: Notable Developments

The global oncology companion diagnostic market has witnessed significant developments in the recent years. One of such developments pertaining to the market is mentioned below:

  • In July 2020, the FDA gave nod to Ventana HER2 Dual ISH DNA Probe Cocktail assay. This newly approved assay is expected to work as a fast and novel method to be used for the detection of HER2 biomarker for breast cancer. This assay is also anticipated to work in the form of companion diagnostic for Herceptin therapy.

Some of the key players in the global oncology companion diagnostic market comprise the below-mentioned:

  • Thermo Fisher Scientific, Inc
  • Myriad Genetics, Inc
  • Agilent Technologies, Inc
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Associated Regional and University Pathologists (ARUP), Inc

Global Oncology Companion Diagnostic Market: Key Trends

The following drivers, restraints, and opportunities characterize global oncology companion diagnostic market over the assessment period, from 2019 to 2027.

Economic Benefits Offered by the Assay to Shoot Up its Demand in the Market

The growth of the global oncology companion diagnostic market is primarily driven by the economic benefits offered by oncology companion diagnostics assays or (CDx). In addition to that, these assays are able to lessen the time taken by clinical trial, which has played an important role in augmenting its uptake by the pharmaceutical manufacturing companies. Companion diagnostics are capable of improving the effects of treatment of various diseases by offering clinicians a crystal clear clinical ground for treatment and diagnosis.  In addition to that, it also helps in managing national insurance policies and patient resources more efficiently through reduction of unnecessary treatment with costly drugs of chemotherapy. This cost effective aspect is likely to foster growth of the global oncology companion diagnostic market over the period of analysis, form 2019 to 2027.

Global Oncology Companion Diagnostic Market: Geographical Analysis

North America is anticipated to exert dominance over the global oncology companion diagnostic market and the trend is likely to continue throughout the tenure of assessment. The region is estimated to account for a large chunk of the total market revenue. Such growth of the North America market is ascribed to the increased grants and funding given by bodies like National Cancer Institute (NCI) so as to speed up the development of precision therapy.

The global oncology companion diagnostic market is segmented as:

Product and Service

  • Instrument
  • Consumables
  • Software
  • Service

Technology

  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Immunohistochemistry (IHC)
  • In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)

Disease Type

  • Breast Cancer
  • Non-Small Cell Lung Cancer
  • Colorectal Cancer
  • Leukemia
  • Melanoma
  • Prostate Cancer

Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Russia
    • Italy
  • Asia Pacific
    • China
    • Japan
    • Korea
    • India
    • Southeast Asia
  • The Middle East
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
  • Latin America
    • Brazil
    • Argentina
    • Colombia

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

The reports offer answers to the top 7 questions that revolve around the growth of the market

  • What are the diverse growth parameters influencing the market?
  • Which regions will contribute largely to the growth of the market
  • What are the recent innovations and technological advancements in the market?
  • What are the emerging trends across the market?
  • How has COVID-19 affected the market?
  • What will be the post-pandemic scenario of the market?
  • What are the major threats that will dent the growth prospects of the market?